To examine a set of proposed eligibility factors for hemi‐ablative focal therapy in prostate cancer and to determine the likelihood of residual extensive disease. Click to show full abstract
To examine a set of proposed eligibility factors for hemi‐ablative focal therapy in prostate cancer and to determine the likelihood of residual extensive disease.
Click one of the above tabs to view related content.